Clinical Trials on DNA Damage in Finland

Total 605 results

Ricard Marcos
Finnish Institute of Occupational Health

Recruiting

Biomonitoring of Occupationally Populations Exposed to Micro and Nanoplastic

Occupational Exposure | Genotoxicity | Damage Dna

Finland, Spain
University of Oulu

Completed

Ischaemic Stroke and Sleep Apnea in Northern Part of Finland

Cerebral Palsy | Sleep Apnoea

Finland
TILT Biotherapeutics Ltd.

Recruiting

TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 Monotherapy (TUNIMO)

Solid Tumor

Finland
Sykehuset Telemark
University of Oslo; Lund University; Oslo University Hospital; University of Minnesota and other collaborators

Recruiting

Pain Burden in Children and Adolescents With Cerebral Palsy (CPPain)

Cerebral Palsy

Canada, United States, Finland, Norway, Sweden
Tampere University Hospital
Helsinki University Central Hospital; Tampere University; Tampere University...

Unknown

Facial Function Reanimation by Electrical Pacing in Unilateral Facial Paralysis.

Facial Nerve Palsy

Finland
Provention Bio, Inc.

Completed

PROtocol for Coxsackievirus VaccinE in Healthy VoluNTteers (PROVENT)

Viral; Infection, Coxsackie(Virus)

Finland
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of FluarixTM Vaccine in Children Who Have Previously Been Vaccinated With PandemrixTM

Influenza

Finland
Novartis Vaccines

Completed

Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children

Influenza

Finland
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers

Influenza

Finland
MedImmune LLC

Completed

Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)

Influenza

Finland
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months

Influenza

Finland
Finnish Institute for Health and Welfare
Hospital District of Helsinki and Uusimaa

Recruiting

Immune Responses in Health Care Personnel

Influenza

Finland
Finnish Institute for Health and Welfare
RWTH Aachen University; University of Erfurt

Completed

Herd Immunity and Influenza Vaccine Uptake (HIIVU)

Influenza, Human

Finland
University of Helsinki
Uppsala University; Göteborg University

Enrolling by invitation

Recovery After Critical Covid-19 Infection (RECOVID)

Covid-19

Finland
Abdul Latif Jameel Poverty Action Lab
Icahn School of Medicine at Mount Sinai

Terminated

Clinical Decision Support (CDS) for Outpatient Radiology Imaging

CT and MR Image Orders

United States
Novartis Vaccines

Completed

Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study

FLU

Finland
Sanofi Pasteur, a Sanofi Company

Terminated

Study to Evaluate the Effectiveness of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Adults 65 Years of Age and Older

Influenza (Healthy Volunteers)

Finland
University of Helsinki
The University Pharmacy, Helsinki

Completed

The Effect of Zinc Acetate Lozenges on the Rate of Recovery From the Common Cold (HelZinki)

Respiratory Tract Infections | Common Cold

Finland
Hospital District of Southwestern Finland
Hoffmann-La Roche

Completed

Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age (ETOPOM)

Influenza

Finland
Jarmo Oksi

Completed

COVID-19: Salvage TOcilizumab as a Rescue Measure (COVIDSTORM)

Covid19

Finland
Novartis Vaccines

Completed

Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years

Prophylaxis of Avian Influenza

Finland
Finnish Institute for Health and Welfare

Completed

Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11

Influenza Caused by the 2009 H1N1 Influenza Virus

Finland
Finnish Institute for Health and Welfare

Completed

Evaluation of Pandemic Vaccination Campaign

Influenza Caused by the Novel A(H1N1)v Influenza Virus

Finland
Clinical Urology and Epidemiology Working Group
Helsinki University Central Hospital; Oulu University Hospital; Kuopio University... and other collaborators

Recruiting

SOLIDARITY Finland Long-COVID (Remdesivir Long-term Follow-up Study of COVID Patients)

Covid19

Finland
Finnish Institute for Health and Welfare
Norwegian Institute of Public Health; Karolinska Institutet

Completed

Tobacco Use and COVID-19 Incidence in the Finnish General Population (Tobrisk-CoV)

Covid19 | SARS-CoV-2 Infection

Finland
Merck Sharp & Dohme LLC

Completed

A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013)

Hepatitis B

Finland
Tampere University Hospital

Active, not recruiting

Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection

COVID-19 | SARS-CoV-2 Infection

Finland
GlaxoSmithKline

Completed

Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b

Finland
Helsinki University Central Hospital

Recruiting

AIR-program and HUS Internet Therapy Compared to Treatment as Usual in Functional Disorders and Post Covid-19 Condition

Functional Disorders | Post Covid-19

Finland
GlaxoSmithKline

Completed

Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b

Finland
Helsinki University Central Hospital
Finnish Red Cross Blood Service

Active, not recruiting

Convalescent Plasma in the Treatment of Covid-19 (CP_COVID-19)

Covid19

Finland
Helsinki University Central Hospital

Recruiting

Functional Ability, Symptoms and Quality of Life in Patients With Post Covid-19 Condition (LC-cohort)

Post Covid-19 Condition

Finland
Clinical Urology and Epidemiology Working Group
Helsinki University Central Hospital; Oulu University Hospital; Kuopio University... and other collaborators

Recruiting

SOLIDARITY Finland Plus Long-COVID

Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Acute Respiratory Disease

Finland
Sanofi

Completed

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2023/24

Influenza Immunization (Healthy Volunteers)

Finland, Germany
Finnish Institute for Health and Welfare
Norwegian Institute of Public Health; Karolinska Institutet

Active, not recruiting

Tobacco Use and Uptake of COVID-19 Vaccinations

Smoking | COVID-19 | Tobacco Use | Vaccination Refusal

Finland
Tampere University Hospital
Tampere University

Recruiting

Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)

Lynch Syndrome | Urothelial Carcinoma

Canada, Finland
Novartis
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects

Pandemic Influenza Disease

Finland, Germany
UKK Institute
University of Eastern Finland; North Karelia Hospital District

Unknown

eHealth Intervention on Physical Activity for Type 2 Diabetics - Frustrated by COVID-19 (MySteps-CoV)

Type2 Diabetes

Finland
University of Helsinki

Completed

Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis

Alcoholic Hepatitis | Alcoholic Cirrhosis

Finland
GlaxoSmithKline

Completed

Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

Infections, Rotavirus

Finland
Helsinki University Central Hospital
Merck Sharp & Dohme LLC

Completed

Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir (OBERAL)

Fatty Liver | Metabolic Syndrome | HIV Seropositivity

Finland
The Miriam Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Targeting Body Image Among Women of Higher Body Weight

Obesity | Overweight | Body Image

United States
Helsinki University Central Hospital

Unknown

PCV13 + Hepatitis A Vaccine for Adults (PCV13+HepA)

Measurement of Immune Response to Prevenar13 | Measurement of Immune Response to Hepatitis A

Finland, Sweden
GlaxoSmithKline

Completed

A Study in Adolescent Females to Explore Cytomegalovirus Infection

Infections, Cytomegalovirus

Finland, United States, Mexico
Ology Bioservices

Completed

Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults

Influenza | Avian Influenza

Austria, Finland
F-star Therapeutics, Inc.
PRA Health Sciences

Terminated

Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus

Hepatitis B | Hepatitis B, Chronic | HBV

Hong Kong
Women and Infants Hospital of Rhode Island
Centers for Disease Control and Prevention

Completed

Clinical Trial of Behavioral Modification to Prevent Congenital Cytomegalovirus (CDC/CMV)

Pregnancy | Cytomegalovirus Infections | Behavior

United States
Sormland County Council, Sweden
Karolinska Institutet; Helsingfors university

Completed

New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Tick-borne Encephalitis

Sweden, Finland
Lars Rombo

Completed

Hepatitis A Vaccine in Patients With Immunomodulating Drugs

Response to Hepatitis A Vaccine

Finland, Sweden
The Miriam Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Targeting Weight and Shape Concern Among Women With High Body Weight

Weight Loss | Overweight and Obesity | Body Image Disturbance

United States

Clinical Trials on DNA Damage in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations